The expression of HMGB2 was significantly higher in Stage-IV ACC, Stage-IV KIRC, and Stage-II/III LIHC than in Stage-I ACC, Stage-I/III KIRC, and Stage-I LIHC, respectively. This evidence concerns the gene HMGB2 and adrenal cortex carcinoma.